What is Christopher Clarke's NPI number?

Christopher Clarke's National Provider Identifier (NPI) is 1013336940, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Christopher Clarke's specialty?

Christopher Clarke is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Christopher Clarke located?

Christopher Clarke's practice location on file with NPPES is 8096 Twin Beech Road, Fairhope, AL 36532-7194.

What is Christopher Clarke's phone number?

The practice phone number listed in the NPPES registry for Christopher Clarke is (251) 279-6520.

Does Christopher Clarke accept Medicare?

Christopher Clarke is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Christopher Clarke's NPI active?

Yes — Christopher Clarke's NPI (1013336940) is active in the NPPES registry as of the last update on 2026-04-22.

IndividualActiveAccepts Medicare

Christopher Clarke, MD

NPI 1013336940 · Pulmonary Disease Physician · Fairhope, AL

Christopher Clarke, MD is a Pulmonary Disease Physician provider in Fairhope, AL (NPI 1013336940).

Provider details

NPI number: 1013336940
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: 36738 (AL)

Practice location

8096 Twin Beech Road

Suite 250

Fairhope, AL 36532-7194

Phone: (251) 279-6520

Fax: (251) 279-6521

Street-level locationGet directions

More AL providers

Mailing address

8096 Twin Beech Rd Ste 250

Fairhope, AL 36532-7194

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense 36738 (AL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(72/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
12 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,323 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	341	$116
Critical Care, First 30-74 Minutes99291	251	$195
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	194	$109
Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060	97	$9
Test to Determine Lung Volumes Using Sensors94726	97	$11
Test to Examine How Well the Lungs Exchange Gases94729	97	$8

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 19 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Montelukast Sodium	377	96
Prednisone	242	145
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	217	57
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	192	73
Budesonide/Glycopyr/Formoterolbrand: Breztri Aerosphere	177	42
Fluconazole	150	93

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$572 across 30 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2014-04-08
Last updated: 2026-04-22
Certified: 2026-04-22

Frequently asked questions

What is Christopher Clarke's NPI number?: Christopher Clarke's National Provider Identifier (NPI) is 1013336940, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Christopher Clarke's specialty?: Christopher Clarke is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Christopher Clarke located?: Christopher Clarke's practice location on file with NPPES is 8096 Twin Beech Road, Fairhope, AL 36532-7194.
What is Christopher Clarke's phone number?: The practice phone number listed in the NPPES registry for Christopher Clarke is (251) 279-6520.
Does Christopher Clarke accept Medicare?: Christopher Clarke is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Christopher Clarke's NPI active?: Yes — Christopher Clarke's NPI (1013336940) is active in the NPPES registry as of the last update on 2026-04-22.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	341	$116
Critical Care, First 30-74 Minutes99291	251	$195
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	194	$109
Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060	97	$9
Test to Determine Lung Volumes Using Sensors94726	97	$11
Test to Examine How Well the Lungs Exchange Gases94729	97	$8

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 19 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Montelukast Sodium	377	96
Prednisone	242	145
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	217	57
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	192	73
Budesonide/Glycopyr/Formoterolbrand: Breztri Aerosphere	177	42
Fluconazole	150	93

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$572 across 30 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments